# Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults

> **NCT00322946** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 84 (estimated)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** rDEN4delta30-4995
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00322946
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-08
- **Final completion:** —
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2009-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322946, "Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00322946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*